AIM
VYGR icon

Assured Investment Management’s Voyager Therapeutics VYGR Stock Holding History

Assured Investment Management’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-33,458
Closed -$640K – 837
2019
Q1 		$640K Sell
33,458
-9,859
-23% -$128K 0.01% 507
2018
Q4 		$407K Buy
43,317
+36,819
+567% +$472K 0.01% 722
2018
Q3 		$123K Sell
6,498
-14,624
-69% -$281K ﹤0.01% 1014
2018
Q2 		$413K Buy
21,122
+742
+4% +$14.7K 0.01% 861
2018
Q1 		$383K Buy
+20,380
New +$440K 0.01% 854

Other funds holding VYGR

TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Assured Investment Management's VYGR Position: Q2 2019 in Review

Assured Investment Management sold out of Voyager Therapeutics (VYGR) in Q2 2019, closing a stake of 33,458 shares — an estimated $640K sold.

Assured Investment Management first reported a position in VYGR in Q1 2018 and held it in 5 quarters. The position peaked at $640K in Q1 2019. 125 funds tracked by Wall St. Rank hold VYGR as of Q2 2019.

  • Assured Investment Management reported no remaining Voyager Therapeutics position as of Q2 2019 after selling out during the quarter.
  • Assured Investment Management sold 33,458 Voyager Therapeutics shares in Q2 2019, an estimated $640K.
  • Assured Investment Management first reported a position in Voyager Therapeutics in Q1 2018 and held it in 5 quarters.
  • Assured Investment Management's Voyager Therapeutics position peaked at $640K in Q1 2019.
  • 125 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q2 2019.

Based on Assured Investment Management's 13F filing for Q2 2019, filed 14 Aug 2019.